We are proud to be able to contribute to the global biomedical research community, and we are so grateful to have you with us in our mission to improve human health.
JAX is applying its expertise in human genomics and mammalian genetics to support the quickly evolving public health crisis caused by the coronavirus pandemic in two important ways:
We are utilizing our expertise and state-of-the-art breeding techniques to rapidly grow a new mouse colony for potential use in coronavirus research. The goal is to provide researchers with the models they need to develop a vaccine.
At our Connecticut-licensed CLIA (Clinical Laboratory Improvement Amendments) and CAP-accredited laboratory in Farmington, CT, we are testing patient samples for a specific RNA signature unique to SARS-CoV-2, the virus that causes COVID-19. JAX is collaborating with several regional hospitals, including MaineGeneral Medical Center in Augusta, Maine; Mount Desert Island (MDI) Hospital in Bar Harbor, Maine; Northern Light Maine Coast Hospital in Ellsworth, Maine; and more than a dozen healthcare facilities in Connecticut, including UConn Health, to offer COVID-19 testing capacity for symptomatic frontline healthcare workers and in-patients.
Researchers around the world count on JAX. Can we count on you?